Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-16-016102
Filing Date
2016-12-21
Accepted
2016-12-21 16:02:55
Documents
1
Period of Report
2016-12-19

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 11518
  Complete submission text file 0001493152-16-016102.txt   13106
Mailing Address C/O IMPRIMIS PHARMACEUTICALS, INC 12264 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address
BAUM MARK L (Reporting) CIK: 0001274282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 162063989

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations